MedTrace Logo

Monitoring and Testing of Blood Pressure in Postpartum Women

NCT05236725 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1607

Last updated 2026-03-19

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to find out the usefulness of checking a woman's blood pressure remotely (at home) for 3 weeks after being discharged from the hospital after having a baby (or babies). Some women can develop hypertension, or high blood pressure, after delivery even if they have not had this problem before or during their pregnancy. Untreated or unknown high blood pressure can lead to medical complications, and if severe, can be life threatening. Monitoring, or checking, remote blood pressure after a woman has delivered her baby (or babies) has been suggested to be a better way to monitor blood pressures without having to stay in the hospital for a longer time after delivery. Other researchers report that women who have checked their blood pressure remotely after delivery found out that this was both possible and acceptable.

Conditions

Interventions

DEVICE

Remote Blood Pressure Cuff

specialized, Bluetooth enabled blood pressure monitoring cuff

DEVICE

Blood pressure monitoring smart phone app, BabyScripts™

app that works with the monitoring cuff

BEHAVIORAL

Instructions

Verbal and written instructions to conduct blood pressure checks at home

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Elizabeth T Jensen, MPH PhD · Atrium Health Wake Forest Baptist

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2025-01-07
Completion
2025-11-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05236725 on ClinicalTrials.gov